3) autosomal dominant polycystic kidney disease
常染色体显性遗传性多囊肾病
1.
Objective:To observe the clinical effect of laparoscopic renal cyst decortication in patients with autosomal dominant polycystic kidney disease.
目的:观察经后腹腔镜肾囊肿去顶减压术治疗常染色体显性遗传性多囊肾病的临床效果。
4) Autosomal dominant polycystic kidney disease
常染色体显性多囊肾病
1.
A Chinese autosomal dominant polycystic kidney disease family probably related to?PKD2 gene;
一个可能与PKD2基因连锁的常染色体显性多囊肾病家系
2.
We combined two dimensional liquid chromatography—tandem mass spectrometry (2D LC-MS/MS) with the method of isotope-coded affinity tag (ICAT) to do comparative analysis between the proteomes of urine, serum and cells from ADPKD patients and normal controls, aiming to find as many proteins as possible which get involved in the pathogenesis of Autosomal dominant polycystic kidney disease (ADPKD).
为尽可能多地寻找与常染色体显性多囊肾病(autosomal dominant polycystic kidney disease,ADPKD)发病相关的蛋白质,我们采用同位素编码的亲和标签技术与二维液相色谱-串联质谱相结合的定量比较蛋白组学方法分别对ADPKD患者与正常成人尿液、血清蛋白质组样品,以及囊肿衬里上皮细胞与正常肾小管上皮细胞的蛋白质组样品进行比较。
3.
Objective:To observe the expression of epidermal growth factor(EGF)and its receptor(EGFR)in the body fluids and renal tissues of rats with autosomal dominant polycystic kidney disease(ADPKD)and to explore their roles in the development of the disease.
目的:观察常染色体显性多囊肾病大鼠体液及肾脏组织中表皮生长因子(EGF)及其受体(EGFR)的表达,探讨二者在多囊肾病发病过程中的作用。
5) ADPKD
常染色体显性多囊肾病
1.
Objective: To investigate the role of celecoxib in the treatment of autosomal dominant polycystic kidney disease(ADPKD).
目的：研究特异性环氧化酶-2抑制剂塞来昔布治疗类似良性肿瘤的常染色体显性多囊肾病(ADPKD)，以阐明该药具有良好的治疗作用。
6) autosomal recessive polycystic kidney disease
常染色体隐性遗传多囊肾病
1.
68%)including 16 cases of autosomal recessive polycystic kidney disease(ARPKD)(34.
包括常染色体隐性遗传多囊肾病(ARPKD)16例(34。
补充资料：婴儿型多囊肾病
婴儿型多囊肾病
infantile polycystic renal disease
是常染色体隐性遗传病，病因不明。两侧肾脏弥漫性病变。皮质似海绵状，扩张的集合管在髓质内形成大小不等的小囊肿，并呈放射状排列到皮质，间质纤维化，肾盂被胀大的肾实质挤压。本病与髓质海绵肾不同，可鉴别诊断。常并发肝纤维化，其并发症是门静脉高压症和胆道感染。在胎儿期已可确诊，并发严重羊水过少和肺发育不全。出生前受母体胎盘的透析，但出生后几天内死于严重肾功能衰竭或呼吸功能不全。如加强呼吸管理及血液透析可延长生命。预后不良。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条